Free Trial

Boston Scientific (BSX) Stock Forecast & Price Target

$76.34
+0.15 (+0.20%)
(As of 06/18/2024 ET)

Boston Scientific - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$76.70
0.47% Upside
High Forecast$95.00
Average Forecast$76.70
Low Forecast$60.00
TypeCurrent Forecast
6/20/23 to 6/19/24
1 Month Ago
5/21/23 to 5/20/24
3 Months Ago
3/22/23 to 3/21/24
1 Year Ago
6/20/22 to 6/20/23
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Buy
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
19 Buy rating(s)
18 Buy rating(s)
17 Buy rating(s)
12 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$76.70$75.32$66.62$54.61
Forecasted Upside0.47% Upside12.68% Upside13.31% Upside15.20% Upside
Get Boston Scientific Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

BSX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BSX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Boston Scientific Stock vs. The Competition

TypeBoston ScientificMedical CompaniesS&P 500
Consensus Rating Score
2.95
2.70
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside0.47% Upside1,068.19% Upside11.31% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/18/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$82.00 ➝ $82.00+7.39%
5/30/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$90.00+20.05%
5/28/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$80.00 ➝ $95.00+26.51%
5/22/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$85.00 ➝ $87.00+15.16%
5/15/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$85.00 ➝ $90.00+22.50%
4/26/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$70.00 ➝ $78.00+6.38%
4/25/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$72.00 ➝ $82.00+11.95%
4/25/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$63.00 ➝ $73.00-0.34%
4/25/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$78.00 ➝ $82.00+12.04%
4/25/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetStrong-Buy ➝ Strong-Buy$73.00 ➝ $85.00+16.14%
4/25/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$74.00 ➝ $90.00+22.97%
4/25/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$72.00 ➝ $78.00+6.14%
4/25/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$72.00 ➝ $82.00+11.58%
4/25/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$79.00 ➝ $84.00+15.21%
3/7/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$65.00 ➝ $77.00+14.21%
2/1/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$58.00 ➝ $68.00+5.44%
12/29/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$64.00+13.72%
12/22/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$59.00 ➝ $66.00+18.22%
12/4/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$58.00 ➝ $61.00+8.64%
11/27/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$60.00 ➝ $64.00+15.17%
9/21/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$58.00 ➝ $60.00+10.91%
7/6/2023Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$58.00 ➝ $62.00+16.43%
6/30/202322nd Century Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingInitiates
6/30/2023CL King
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$64.00+20.10%
10/12/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$50.00+26.39%
7/5/2022Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$43.00+13.88%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:03 AM ET.

BSX Forecast - Frequently Asked Questions

What is Boston Scientific's stock forecast and purchase recommendation?

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Boston Scientific is $76.70, with a high forecast of $95.00 and a low forecast of $60.00. The consensus rating for Boston Scientific stock is Moderate Buy based on the current 2 hold ratings, 19 buy ratings and 1 strong buy rating for BSX. Learn more on BSX's analyst rating history.

Do Wall Street analysts like Boston Scientific more than its competitors?

Analysts like Boston Scientific more than other "medical" companies. The consensus rating score for Boston Scientific is 2.95 while the average consensus rating score for "medical" companies is 2.70. Learn more on how BSX compares to other companies.

Does Boston Scientific's stock price have much upside?

According to analysts, Boston Scientific's stock has a predicted upside of 13.20% based on their 12-month stock forecasts.

What analysts cover Boston Scientific?

Stock Forecasts and Research Tools

This page (NYSE:BSX) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners